546 — Medtecs International Income Statement
0.000.00%
Last trade - 00:00
- SG$71.93m
- SG$65.36m
- $52.63m
- 58
- 49
- 50
- 53
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 69 | 400 | 144 | 56.2 | 52.6 |
Cost of Revenue | |||||
Gross Profit | 10.5 | 172 | 42 | -3.34 | 6 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 65.2 | 264 | 126 | 86.9 | 75.8 |
Operating Profit | 3.79 | 137 | 17.8 | -30.6 | -23.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.52 | 135 | 16.9 | -30.7 | -22.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.17 | 132 | 16.5 | -29.3 | -22.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1.16 | 132 | 17.3 | -28.6 | -21 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.16 | 132 | 17.3 | -28.6 | -21 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.002 | 0.24 | 0.032 | -0.053 | -0.037 |
Dividends per Share |